Form 8-K Olema Pharmaceuticals, For: Jan 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Olema Pharmaceuticals reports cash exceeds $500 million at year-end
January 12, 2026 4:47 PM ESTOlema Pharmaceuticals Inc. (NASDAQ: OLMA) announced its preliminary unaudited cash, cash equivalents and marketable securities exceeded $500 million as of December 31, 2025.
The company disclosed the preliminary financial figure on January 12, 2026, noting it has not completed its fiscal year-end financial close process for 2025. The... More
